A Ki-67 Index to Predict Treatment Response to the Capecitabine/Temozolomide Regimen in Neuroendocrine Neoplasms: A Retrospective Multicenter Study
Wei Wang(Sun Yat-sen University), Jie Chen(Jiangsu University), Yu Zhang(Wannan Medical College), Ying Peng(Shaanxi Normal University), Yao Liang(Sun Yat-sen University), Yuanliang Li(China-Japan Friendship Hospital), Huangying Tan(China-Japan Friendship Hospital), Kaizhou Jin(Shanghai Medical College of Fudan University), Xianjun Yu(Fudan University Shanghai Cancer Center)
Cited by 30
Related Papers
Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium
|Stem Cell Research & Therapy|2019|294
MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G
|Cancer Letters|2008|216
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆
|Annals of Oncology|2021|212
Head and neck tumor segmentation in PET/CT: The HECKTOR challenge
|Medical Image Analysis|2021|202